News about Biotechnology

UK Regulator Pushes Shift Toward Reduced Animal Testing, Issues Roadmap for Alternative Methods

The UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency, has outlined new guidance aimed at reducing reliance on animal testing and accelerating the adoption of alternative scientific methods in drug development.

Biotechnology | 26/03/2026 | By Darshana |  144

Alteogen and Biogen Sign Deal for Hybrozyme-Based Subcutaneous Biologics

Alteogen signs a licensing deal with Biogen to develop and commercialise Hybrozyme-based subcutaneous biologics, granting rights for two products using the ALT-B4 platform.

Biotechnology | 26/03/2026 | By News Bureau |  336

Biocytogen Pharmaceuticals Beijing Partners Moonlight Bio to Advance Next-Generation Cancer Cell Therapies

The strategic collaboration between Biocytogen Pharmaceuticals Beijing and Moonlight Bio aims to combine antibody discovery and cell therapy expertise to develop innovative treatments for hard-to-treat cancers.

Biotechnology | 25/03/2026 | By News Bureau |  226

Co-Diagnostics Expands CoSara's South Asia Footprint, Targets USD 13 Billion Diagnostics Market

Co-Diagnostics, Inc. has announced a strategic expansion of its South Asia operations through its joint venture CoSara Diagnostics Pvt. Ltd., formed in partnership with Ambalal Sarabhai Enterprises Limited.

Biotechnology | 23/03/2026 | By Darshana |  195

From Generics to Biologics: Semaglutide Reshapes Pharma Manufacturing in India

The recent developments around semaglutide in India—triggered by patent expiry and rapid domestic entry—are poised to significantly reshape the country’s pharmaceutical manufacturing landscape.

Biotechnology | 23/03/2026 | By Darshana |  249

Belief Pharmaceuticals Group Has Announced that its Gene Therapy BM-H901 Injection Has Received Approval from the Macau

Belief Pharmaceuticals Group has announced that its gene therapy BM-H901 injection (generic name: Popedacoq injection) has received approval from the Macau Drug Administration for treating adult patients with moderate to severe haemophilia B (congenital factor IX deficiency).

Biotechnology | 22/03/2026 | By Darshana |  184

GI Innovation, Johnson & Johnson Partner for Phase Ib Trial in Advanced Prostate Cancer

GI Innovation enters clinical supply agreement with Johnson & Johnson to evaluate GI-102 and pasritamig combination therapy in metastatic castration-resistant prostate cancer patients.

Biotechnology | 21/03/2026 | By News Bureau |  255

Zydus Lifesciences Launches Aerolife Mini, India's First Portable Foldable Spacer

Zydus introduces Aerolife Mini, a compact pMDI enhancer designed to improve inhaler drug delivery and patient compliance in respiratory care through a convenient, foldable design.

Biotechnology | 20/03/2026 | By News Bureau |  267

Samsung Bioepis Partners with Sandoz for Next-Gen Biosimilar Candidates

Samsung Bioepis has partnered with Sandoz to develop and commercialise up to five biosimilar candidates, including SB36 (vedolizumab), across global markets, excluding select Asian regions, strengthening its pipeline in immunology and oncology.

Biotechnology | 19/03/2026 | By News Bureau |  229

Aplagon Doses First Patient in Phase IIa Trial of APAC for Chronic Limb-Threatening Ischemia

Aplagon has dosed the first patient in its Phase IIa HEALING trial evaluating APAC therapy for Chronic Limb?Threatening Ischemia caused by Peripheral Arterial Occlusive Disease in Finland.

Biotechnology | 16/03/2026 | By News Bureau |  211